Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Victoza summary of product characteristics
Article Summary GLP 1 medications such as Semaglutide and Tirzepatide create steady appetite reduction, improved metabolic balance, and consistent fat loss over several weeks
Big bets on new molecules / combinations: Investors are committing large rounds to next-gen GLP-1, GLP-1/GIP combos, amylin analogs, and oral formulations
Additionally, the weight loss associated with GLP-1 agonists may be a problem for the many people with Parkinsons who experience unintended weight loss through the course of the disease
Monitoring and adjustment protocols should include: Weight and vital signs at each visit (initially monthly, then quarterly) Assessment of medication tolerance and adherence Evaluation of eating behaviors and physical activity Laboratory monitoring as outlined previously Reassessment of weight-related comorbidities Realistic expectations should be established through shared decision-making
